Now showing items 1-1 of 1

    • MRP3: a molecular target for human glioblastoma multiforme immunotherapy. 

      Bigner, DD; Herndon, James Emmett II; Kuan, Chien-Tsun; Lipp, Eric S; McLendon, Roger E; Pegram, CN; Rasheed, A; ... (11 authors) (BMC Cancer, 2010-09-01)
      BACKGROUND: Glioblastoma multiforme (GBM) is refractory to conventional therapies. To overcome the problem of heterogeneity, more brain tumor markers are required for prognosis and targeted therapy. We have identified and ...